Pharma-Bio Serv adopts amended bylaws adding advance notice, supermajority vote requirement

Pharma-Bio Serv, Inc.

Advance notice bylaw established as exclusive means for stockholder proposals and nominations.
Stockholder action by written consent requires delivery within 60 days and proper method per DGCL.
Board now solely sets board size; vacancies filled by remaining directors.
Stockholder amendments to bylaws require 66 2/3% supermajority vote.
Indemnification provisions added for directors, officers, employees, and agents.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Pharma-Bio Serv, Inc.: Adopted amended and restated bylaws including advance notice for stockholder business, revised stockholder action by written consent, board size and vacancy filling, indemnification, and supermajority vote for bylaw amendments (effective 2023-02-08).

Change: bylaw amendment
Effective: 2023-02-08

Exact text from the filing

On February 8, 2023, the Board of Directors (the “Board”) of Pharma-Bio Serv, Inc. (the “Company”) adopted the Amended and Restated ByLaws of the Company (the "Amended ByLaws"), effective as of such date.

View on SEC.gov

Browse all governance changes →

Pharma-Bio Serv, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-23-001509

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.